UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Raised by Spectrum Asset Management Inc. NB CA

Spectrum Asset Management Inc. NB CA boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 414.4% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 5,952 shares of the healthcare conglomerate’s stock after buying an additional 4,795 shares during the period. UnitedHealth Group accounts for approximately 1.5% of Spectrum Asset Management Inc. NB CA’s holdings, making the stock its 27th biggest holding. Spectrum Asset Management Inc. NB CA’s holdings in UnitedHealth Group were worth $3,480,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. Macroview Investment Management LLC lifted its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth approximately $32,000. Finally, Delos Wealth Advisors LLC grew its stake in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $564.48 on Thursday. The firm has a market cap of $521.25 billion, a P/E ratio of 36.77, a PEG ratio of 1.67 and a beta of 0.58. The firm’s 50 day moving average price is $584.16 and its two-hundred day moving average price is $536.49. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the company earned $6.56 earnings per share. The firm’s revenue was up 9.2% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Robert W. Baird boosted their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.